Aurora Cannabis missed Q3 earnings estimates significantly, reporting an EPS of $-0.18 compared to the expected $-0.05. This is likely to negatively impact the stock price in the short term, as investors may be disappointed with the company's performance. Additionally, the company's history of missing earnings estimates and the subsequent share price drop last quarter further supports the expectation of a negative impact on the stock price.